Apolipoprotein E allele-dependent pathogenesis: A model for age-related retinal degeneration

被引:221
作者
Malek, G
Johnson, LV
Mace, BE
Saloupis, P
Schmechel, DE
Rickman, DW
Toth, CA
Sullivan, PM
Rickman, CB
机构
[1] Duke Univ, Med Ctr, Dept Ophthalmol, Durham, NC 27710 USA
[2] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA
[3] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA
[4] Duke Univ, Med Ctr, Dept Med, Div Neurol, Durham, NC 27710 USA
[5] Duke Univ, Med Ctr, Joseph & Kathleen Bryan Alzheimers Dis Res Ctr, Durham, NC 27710 USA
[6] Univ Calif Santa Barbara, Neurosci Res Inst, Ctr Study Macular Degenerat, Santa Barbara, CA 93106 USA
关键词
amyloid choroidal neovascularization; macula; retinal pigment epithelium; cholesterol;
D O I
10.1073/pnas.0503015102
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Age-related macular degeneration (AMD) is a late-onset, multifactorial, neurodegenerative disease of the retina and the leading cause of irreversible vision loss in the elderly in the Western world. We describe here a murine model that combines three known AMD risk factors: advanced age, high fat cholesterol-rich (HF-C) diet, and apolipoprotein E (apoE) genotype. Eyes of aged, targeted replacement mice expressing human apoE2, apoE3, or apoE4 and maintained on a HF-C diet show apoE isoform-dependent pathologies of differential severity. ApoE4 mice are the most severely affected. They develop a constellation of changes that mimic the pathology associated with human AMD. These alterations include diffuse sub-retinal pigment epithelial deposits, drusenoid deposits, thickened Bruch's membrane, and atrophy, hypopigmentation, and hyperpigmentation of the retinal pigment epithelium. In extreme cases, apoE4 mice also develop marked choroidal neovascularization, a hallmark of exudative AMD. Neither age nor HF-C diet alone is sufficient to elicit these changes. We document choroidal neovascularization and other AMD-like ocular pathologies in an animal model that exploits known AMD risk factors. The model is additionally attractive because it is not complicated by invasive experimental intervention. Our findings in this model implicate the human apoE E4 allele as a susceptibility gene for AMD and support the hypothesis that common pathogenic mechanisms may underlie AMD and Alzheimer's disease.
引用
收藏
页码:11900 / 11905
页数:6
相关论文
共 61 条
[21]   Complement factor H variant increases the risk of age-related macular degeneration [J].
Haines, JL ;
Hauser, MA ;
Schmidt, S ;
Scott, WK ;
Olson, LM ;
Gallins, P ;
Spencer, KL ;
Kwan, SY ;
Noureddine, M ;
Gilbert, JR ;
Schnetz-Boutaud, N ;
Agarwal, A ;
Postel, EA ;
Pericak-Vance, MA .
SCIENCE, 2005, 308 (5720) :419-421
[22]  
HALLMAN DM, 1991, AM J HUM GENET, V49, P338
[23]  
Hawes N L, 1999, Mol Vis, V5, P22
[24]   APPLICATION OF ACRYLAMIDE AS AN EMBEDDING MEDIUM IN STUDIES OF LECTIN AND ANTIBODY-BINDING IN THE VERTEBRATE RETINA [J].
JOHNSON, LV ;
BLANKS, JC .
CURRENT EYE RESEARCH, 1984, 3 (07) :969-974
[25]   Arteriosclerosis, apolipoprotein E, and Alzheimer's disease [J].
Kalaria, RN .
LANCET, 1997, 349 (9059) :1174-1174
[26]  
KIMURA H, 1995, INVEST OPHTH VIS SCI, V36, P2110
[27]   Genetic association of apolipoprotein E with age-related macular degeneration [J].
Klaver, CCW ;
Kliffen, M ;
van Duijn, CM ;
Hofman, A ;
Cruts, M ;
Grobbee, DE ;
van Broeckhoven, C ;
de Jong, PTVM .
AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 63 (01) :200-206
[28]   Complement factor H polymorphism in age-related macular degeneration [J].
Klein, RJ ;
Zeiss, C ;
Chew, EY ;
Tsai, JY ;
Sackler, RS ;
Haynes, C ;
Henning, AK ;
SanGiovanni, JP ;
Mane, SM ;
Mayne, ST ;
Bracken, MB ;
Ferris, FL ;
Ott, J ;
Barnstable, C ;
Hoh, J .
SCIENCE, 2005, 308 (5720) :385-389
[29]   The APO*E3-Leiden mouse as an animal model for basal laminar deposit [J].
Kliffen, M ;
Lutgens, E ;
Daemen, MJAP ;
de Muinck, ED ;
Mooy, CM ;
de Jong, PTVM .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2000, 84 (12) :1415-1419
[30]   Apo E structure determines VLDL clearance and atherosclerosis risk in mice [J].
Knouff, C ;
Hinsdale, ME ;
Mezdour, H ;
Altenburg, MK ;
Watanabe, M ;
Quarfordt, SH ;
Sullivan, PM ;
Maeda, N .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (11) :1579-1586